The Role of Subjective Age in the System of Psychological Factors in the Course of the Disease in Men with Prostate Cancer. Part I. Subjective Age and Quality of Life in Men with Prostate Cancer

Relevance. Prostate cancer remains one of the major public health problems worldwide, as it is accompanied by high rates of morbidity and mortality. Purpose. The work is devoted to the study of the role of subjective age in the system of psychological factors of the course of the disease in men with prostate cancer; in this part of the work, attention is focused on the relationship between subjective age and quality of life. Materials and methods. The study involved 127 men aged 53 to 85 years (М=68; Ме=69; SD=10,27) diagnosed with prostate cancer (stage I of the disease – 16 men; stage II – 64; stage III – 13; IV – 34; favorable course of the disease – 40 people, unfavorable - 61). In addition to socio-demographic data, subjective age was studied (B. Barak questionnaire in adaptation by E.A. Sergienko, 2011), quality of life – subjective health assessments (SF-36 questionnaire in adaptation by K.G. Gurevich, E.G. Fabrikant, 2008). This work consists of two parts describing the role of subjective age in the system of psychological factors in men with prostate cancer. Part I of the article is devoted to the analysis of the role of subjective age and quality of life assessments. Three subgroups were identified according to estimates of subjective age: those who feel younger than their passport age (80 people), adequate to their age (44 people) and older (3 people). Results and conclusions. The analysis of men with different perceptions of subjective age with a favorable and unfavorable course of the disease was carried out. It is shown that men who feel younger concentrate on the physical aspects of health and their own vitality, fearing for the level of their own activity and compliance with gender functioning, regardless of the prosperous/dysfunctional course of the disease.

1. Vagajceva M.V. Otnoshenie k bolezni u muzhchin s diagnozom raka predstatel'noj zhelezy posle hirurgicheskogo lecheniya [Attitude to the disease in men diagnosed with prostate cancer after surgical treatment]. Dissertaciya na soiskanie uchenoj stepeni kandidata psihologicheskih nauk = Dissertation for the degree of Candidate of Psychological Sciences. St. Petersburg, 2017. 197 p. (In Russ.)
2. Gurevich K.G., Fabrikant E.G. Metodicheskie rekomendacii po organizacii programm profilaktiki hronicheskih neinfekcionnyh zabolevanij [Methodological recommendations for the organization of programs for the prevention of chronic non-communicable diseases] [Elektronnyj resurs]. Moskwa: GOU VPO Moskovskij gosudarstvennyj mediko-stomatologicheskij universitet = Methodological recommendations for the organization of programs for the prevention of chronic non-communicable diseases, 2008. URL: http://bono-esse.ru/blizzard/RPP/M/ORGZDRAV/Orgproga/org_proga.html (Accessed 14.08.2023).
3. Kel'n A.A., Alifov D.G., Zvezda S.A., Zasorina M.A. Vzaimosvyaz' raka predstatel'noj zhelezy s razvitiem depressii i suicidal'nyh myslej [The relationship of prostate cancer with the development of depression and suicidal thoughts]. Vestnik urologii = Bulletin of Urology, 2022, № 10 (1), pp. 104–109. DOI: 10.21886/2308-6424-2022-10-1-104-109. (In Russ., abstr. in Engl).
4. Salihar R.I., Tumanbaev A.M., Kerimov A.D., Kamarli Z.P., Makimbetov E.K. Epidemiologiya raka predstatel'noj zhelezy [Epidemiology of prostate cancer]. Nauchnoe obozrenie. Medicinskie nauki. = Scientific review. Medical sciences, 2020, № 3, pp. 15–20. (In Russ., abstr. in Engl.).
5. Sergienko E.A. Sub"ektivnyj vozrast kak prediktor techeniya tyazheloj bolezni [Subjective age as a predictor of the course of a serious illness]. Vestnik RGGU. Seriya «Psihologiya. Pedagogika. Obrazovanie» = Bulletin of the Russian State University. The series "Psychology. Pedagogy. Education", 2020, № 1, pp. 25–39. (In Russ., abstr. in Engl.).
6. Sergienko E.A., Tsiring D.A., Pahomova YA.N., Ponomareva I.V. Sub"ektivnyj vozrast zhenshchin s rakom molochnoj zhelezy v sisteme psihologicheskih faktorov [Subjective age of women with breast cancer in the system of psychological factors]. Klinicheskaya i special'naya psihologiya = Clinical and special psychology, 2022, vol. 11, № 1, pp. 67–89. (In Russ., abstr. in Engl.).
7. Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 godu [The state of oncological care to the population of Russia in 2021]. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. SHahzadovoj. M.: MNIOI im. P.A. Gercena, 2022. 239 p. (In Russ.).
8. Brown T.H. Diverging Fortunes: Racial Ethnic Inequality in Wealth Trajectories in Middle and Late Life. Race Soc Probl., 2016, vol. 8, pp. 29–41. DOI: 10.1007/s12552-016-9160-2
9. Lima M.M., Tobias‐Machado M. Suicide in patients with genitourinary malignancies [Elektronnyi resurs]. European journal of cancer care, 2017, vol. 26, № 6, e12635. URL: https://pubmed.ncbi.nlm.nih.gov/28134462/ (Accessed 01.07.2023).
10. Dickey S.L., Motolani E., Pharm, O.B. Quality of Life Among Black Prostate Cancer Survivors: An Integrative Review. American Journal of Men’s Health, 2018, vol. 12, № 5, pp. 1648–1664. DOI: 10.1177/1557988318780857
11. Dinh K.T., Reznor G, Muralidhar V., Mahal B.A., Nezolosky M.D., Choueiri T.K., Hoffman K.E., Hu J.C., Sweeney C.J., Trinh Q.D., Nguyen P.L. Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer. J Clin Oncol., 2016, vol. 34, № 16, pp. 1905–1912. DOI: 10.1200/JCO.2015.64.1969
12. Ediebah D. E., Quinten C., Coens C., Ringash J., Dancey J., Zikos E. Canadian Cancer Trials Group and the European Organization for Research and Treatment of Cancer. Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from Canadian cancer trials group clinical trials. Cancer, 2018, vol. 124, № 16, pp. 409–416.
13. Epidemiology of Prostate Cancer. World J Oncol, 2019, vol.10, № 2, pp. 63–89. DOI: 10.14740/wjon1191/.
14. Erim D.O., Bennett A.V., Gaynes B.N., Basak R.S., Usinger D, Chen R.C. Associations between prostate cancer-related anxiety and health-related quality of life. Cancer Med., 2020, vol. 9, № 12, pp. 4467–4473. DOI: 10.1002/cam4.3069
15. Esser P., Mehnert-Theuerkauf A, Friedrich M., et al. Risk and associated factors of depression and anxiety in men with prostate cancer: Results from a German multicenter study. Psycho‐oncology, 2020, vol. 29, № 10, pp. 1604–1612.
16. Feller S., Teucher B., Kaaks R., Boeing H., Vigl M. Life satisfaction and risk of chronic diseases in the European prospective investigation into cancer and nutrition (EPIC)-Germany study [Elektronnyi resurs]. PloS one, 2013, vol. 8, № 8, e73462. URL: https://doi.org/10.1371/journal.pone.0073462 (Accessed 01.06.2023).
17. Fenton J.J., Weyrich M.S., Durbin S., Liu Yu., Bang H., Melnikow J. Prostate-Specific Antigen–Based Screening for Prostate Cancer.Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 2018, № 319 (18), pp. 1914–1931. DOI: 10.1001/jama.2018.3712
18. Groarke A., Curtis R., Skelton J., Groarke J.M. Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience [Elektronnyi resurs]. PLoS ONE, 2020, vol. 15, № 9, e0239469. URL: https://doi.org/10.1371/journal.pone.0239469 (Accessed 01.08.2023).
19. Jahnen M., Lehner L., Meissner V.H., Dinkel A., Schiele S., Schulwitz H., Herkommer K. Cancer-related self-perception in men affected by prostate cancer after radical prostatectomy. Journal of Cancer Survivorship, 2022, № 18 (2), pp. 18–41.
20. Krishnan V., Nestler E.J. Linking Molecules to Mood: New Insight Into the Biology of Depression. Am J Psychiatry, 2010, vol. 167, pp. 1305–1320. DOI: 10.1176/appi.ajp.2009.10030434
21. Lavalette C., Tretarre B., Rebillard X. Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study. Oncotarget, 2018, vol. 9, pp. 485–494. DOI: 10.18632/oncotarget.26128
22. Lepore S.J., Helgeson V.S. Social constraints, intrusive thoughts and mental health after prostate cancer. J Soc Clin Psychol, 1998, vol. 17, pp. 89–106.
23. McGinley K.F., Tay K.J., Moul J.W. Prostate cancer in men of African origin. Nat Rev Urol, 2017, vol.13, pp. 99–107. DOI: 10.1038/nrurol.2015.298
24. Odedina F.T., Akinremi T.O., Chinegwundoh F. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer, 2009, vol. 4, pp. 2. DOI: 10.1186/1750-9378-4-S1-S2
25. Reiche E.M.V., Nunes S.O.V., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol, 2004, vol. 5, pp. 617–625. DOI: 10.1016/S1470-2045(04)01597-9
26. Schroder F.H. Prostate cancer around the world: an overview. Urol Oncol, 2010, vol. 28, pp. 663–667.
27. Smith R.A., Andrews K.S., Brooks D., Fedewa S.A., Manassaram‐Baptiste D., Saslow D., Wender R.C. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. Cancer journal for clinicians, 2019, vol. 69, no 3, pp. 184–210.
28. Tripp D.A., Mihajlovic V., Fretz K., Fervaha G., Izard J., Corby R., Siemens D.R. Quality of life, depression, and psychosocial mechanisms of suicide risk in prostate cancer. Can Urol Assoc J, 2020, vol. 14, № 10, 487–492. DOI: 10.5489/cuaj.6310
29. Ware J.E.J., Kosinski M., Keller S.D. SF-36 physical and mental health summary scale: a user’s manual. Boston, MA: The Health Institute, New England Medical Centre, 1994.188 p.
30. White V.M., English D.R., Coates H., Lagerlund M., Borland R., Giles G.G. Is cancer risk associated with anger control and negative affect? Findings from a prospective cohort study. Psychosomatic medicine, 2007, vol. 69, № 7, pp. 667–674.
31. Zamora D., Gordon-Larsen P., Jacobs D.R., Popkin B.M. Diet quality and weight gain among black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study (1985–2005). Am J Clin Nutr, 2010, vol. 92, pp. 784–793. DOI: 10.3945/ajcn.2010.29161